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Glossopteris Dynamic signaling networks are required to perform complex cellular processes. Structural and functional data now indicate the intriguing possibility that extracellular bacterial pathogens use catalytic scaffolds to assemble unique supramolecular signaling networks that effectively subvert key cellular processes in the host.
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Under appropriate environmental conditions, intracellular and extracellular pathogens may use a type III secretion system to deliver a pool of pre-formed effector proteins into the cytosol of host eukaryotic cells to subvert their molecular processes for the needs of the bacteria [1] . The nature of the bacterial effectors involved and the mechanisms that allow them to affect host signaling are only partially known. Several bacterial effectors have been identified for some intracellular pathogens, such as IcsA of Shigella, ActA of Listeria, and RickA of Rickettsia. These proteins target the host actin regulators N-WASP and Arp2/3 complex, which are required for the actin-based propulsion that facilitates bacterial survival in the host cytosol and invasion of adjacent cells [2] . Conversely, extracellular pathogens, including the closely related enterohemorrhagic Escherichia coli O157:H7 (EHEC) and enteropathogenic E. coli (EPEC), do not enter the host cells, but intimately adhere to the host plasma membrane to drive changes in the host cytoskeleton. By formation of pedestals rich in filamentous actin (F-actin) under the host cell membrane, these food-borne pathogens induce striking lesions of the intestinal epithelium and thus trigger severe infantile diarrhea [3] . A study by Selyunin et al. [4] , recently published in Nature, now provides new fascinating evidence on the ability of a single EHEC effector protein to organize supramolecular signaling networks by co-opting two different enzymes from the host cytosol. Scaffolding proteins are known to assemble signaling networks to faithfully regulate cell behavior [5] . An important question is how can effectors from extracellular bacteria efficiently reorganize the host signaling networks according to the needs of the bacteria. Pathogens have already been shown to inhibit individual host enzymes [6] . Moreover, recently they were shown to provide scaffolding for the reorganization of host signaling networks. Alto et al. [7] demonstrated that the EPEC type III effector EspF interacts with two host proteins -the sorting nexin SNX9, which is involved in the formation of endocytic vesicles [8] , and the actin polymerization promoter N-WASP. The assembly of this complex causes the remodeling of the eukaryotic endocytic membranes, as a consequence of the recruitment and activation of N-WASP-Arp2/3-mediated F-actin nucleation at these membranes. Interestingly, the SNX9 SH3 domain, which is responsible for EspF binding, can interact directly with N-WASP [9] . Therefore, the insertion of the bacterial EspF effector, by preventing the direct association between the two host proteins, may affect normal membrane traffic and actin reorganization, thus playing an important role in the pathogenesis.
Another example of reorganization of the host signaling networks is represented by the localized changes of the host cytoskeleton by EHEC type III effectors [10] . Type III secretion systems allow the intimate attachment of the bacterium to the host via the interaction of the bacterial outer-membrane protein intimin with the EHEC transmembrane effector Tir, which is inserted into the eukaryotic cell membrane [11] (Figure 1A ). Tir then recruits host N-WASP, which interacts physically with, and is activated by, the proline-rich bacterial effector EspF U . This complex affects the actin pool and thus reorganizes the cytoskeleton of the eukaryotic host cell, with ensuing formation of pedestals under the bacteria [12] . The EHEC effectors Tir and EspF U do not interact directly, but once translocated into the host cell they bind to distinct domains of the host adaptor protein IRSp53/IRTKS. The formation of this ternary complex is needed to activate N-WASP and to promote the vigorous assembly of F-actin required for pedestal formation at the site of bacterial attachment [10] .
Pathogenic E. coli delivers its effector protein EspG into the host cell through a type III secretion apparatus [13] . In the new study, Selyunin et al. [4] used a functional screen to identify new signaling pathways targeted by bacterial pathogens and found that EspG from EHEC localizes at the cis-Golgi, and disrupts the Golgi and endocytic recycling compartments. The authors identified various members of the ARF GTPase family and of the PAK serine/threonine kinase family as possible host targets of EspG. ARF GTPases regulate the vesicular trafficking to and from different types of organelle [14] , while PAKs are effectors acting downstream of the Rho family GTPases Cdc42 and Rac1 [15] , two essential regulators of cell polarity and actin dynamics at the leading edge of the cell [16] . Selyunin et al. [4] also reported the intriguing finding that EspG acts as a catalytic scaffold that concomitantly modifies the activities of these two host enzymes by assembling with them into a trimeric complex. 
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Arf1 GTP (1), Cdc42 can activate both the F-actin promoter N-WASP and the adaptor protein IRSp53, which in turn can also bind directly to N-WASP, with consequent enhancement of Arp2/3-complex-mediated F-actin polymerization. After infection (2), EHEC translocates two effectors into the host cell to trigger localized actin assembly and pedestal formation: Tir is inserted in the host cell membrane, and binds directly to the I-BAR (inverse BAR) domain of the host adaptor IRSp53. Moreover, the Src homology 3 (SH3) domain of IRSp53 interacts directly with the proline-rich bacterial effector EspF U [10] . EspF U in turn recruits and activates N-WASP [12] , resulting in Arp2/3-complex-mediated F-actin nucleation and pedestal formation at sites of bacterial adhesion. (B) Enzymatic scaffolding by the EHEC effector EspG. In the uninfected cell (1), inactive PAK dimers can be activated by binding of active Rac or Cdc42 GTPase to the PAK GTPase-binding domain (GBD)/autoinhibitory domain (AID). This results in the removal of the autoinhibition of the kinase and consequently to its activation and regulation of cytoskeletal dynamics and cell motility [15] . ARF GTPases are inactivated by ARF-GAPs and activated by ARF guanine nucleotide exchange factors (ARF-GEFs) regulating the GTP/GDP cycle (2), which is essential for normal membrane trafficking events at intracellular compartments. In the infected cell (3), the bacterial effector EspG induces the unique assembly of a complex between itself and the eukaryotic enzymes ARF and PAK, causing concomitant inhibition of ARF function and activation of the PAK kinase [4] .
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EspG interacts directly both with the GTPase domain of ARF proteins and with the kinase autoinhibitory domain (AID) of PAK ( Figure 1B) . These findings provide a mechanistic explanation of the observed EspG-induced perturbations of the trafficking of host secretory proteins [4, 17] .
The classical GDP/GTP cycle of ARFs is characterized by structural nucleotide-sensitive changes involving the switch 1 and 2 regions [18] . By combining structural, biochemical, and mutational analysis, Selyunin et al. [4] demonstrated that the bacterial effector EspG interacts selectively with the active GTP-bound form of ARF GTPases but not with the inactive GDP-bound form. By exploiting an uncommon set of interactions with the GTPase, EspG immobilizes the switch 1 region to the structural scaffold of the GTPase, thus stabilizing the GTP-bound conformation of ARF. ARF effectors bind to a hydrophobic area of the GTPase including the switch 1 and 2 regions [19] . Conversely, EspG binds directly to the nucleotide-binding pocket of ARF, and prevents GTP hydrolysis by hampering the binding of the ARF GTPaseactivating protein (ARF-GAP) to ARF ( Figure 1B ). These structural data support the hypothesis that the disruptive effects of EspG on the Golgi apparatus are caused by alterations in vesicular trafficking resulting from the inhibition of the normal ARF GTP/GDP cycle required for proper membrane transport events.
Concomitantly with ARF inhibition, EspG was found to stimulate the kinase activity of PAK [4] . This happens because PAK2 binds EspG on a site adjacent to, but not overlapping with, the ARF-binding site. The authors established that EspG binds the highly conserved Ia3-helix within the AID of PAK2. Comparative analysis of the structure of EspG-PAK2-Ia3 with that of the Ia3 peptide in the autoinhibited PAK1 homodimer revealed a novel allosteric mechanism of PAK activation by EspG, in which EspG displaces the Ia3 helix to allow the initiation of the kinase reaction. Interestingly, the authors found that, although binding of either EspG or Cdc42 to PAK2 stimulates the kinase activity to a similar extent, the structural mechanisms underlying PAK activation [20] are different in the two cases, pointing to a unique mechanism of catalytic scaffolding by the bacterial effector. Moreover, the data presented by Selyunin et al. [4] support the hypothesis that activated ARF1 can recruit the bacterially-driven trimeric ARF1-EspG-PAK2 complex at the cytoplasmic face of Golgi cisternae and suggest that similar hybrid trimers, including EspG in association with different combinations of ARF and/or PAK family members, may be recruited at other host compartments.
In conclusion, the intriguing findings by Selyunin et al. [4] demonstrate that the bacterial effector EspG acts as a catalytic scaffold to create an atypical enzymatic complex by unusually linking the inhibition of ARF GTPases with the activation of PAK kinases at specific subcellular sites. By this new mechanism, bacteria, via specific effectors, manage to cheat the host cell to create novel, unique signaling networks and to reorganize in time and space the activation of the molecular components borrowed by the host. As a consequence, bacteria manage to modify membrane traffic, cytoskeletal dynamics, and possibly other processes to their own needs. The advantages of this strategy may be twofold: the creation of a molecular setting adapted to the bacterial-specific requirements, and also the removal of the hijacked host molecules from the competition with endogenous processes within the eukaryotic cell. This strategy may not be restricted to the EspG of EHEC, since homologous effectors from other bacteria may form enzyme scaffolds on a similar principle. Whether and how these unique supramolecular complexes translate into an asset for the bacterial pathogens remains a fascinating question to be addressed in future studies.
